Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study
Titel:
Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study
Auteur:
Basso, U. Fratino, L. Brunello, A. Lumachi, F. De Salvo, G.L. Lonardi, S. Ghiotto, C. Koussis, H. Pasetto, L.M. Monfardini, S.